Your session is about to expire
← Back to Search
Behavioural Intervention
Risk Assessment for HIV (MOST:PrEP Trial)
N/A
Waitlist Available
Led By Elizabeth Lockhart, PhD
Research Sponsored by Henry Ford Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up year 1 and year 5 electronic health record data pull.
Awards & highlights
MOST:PrEP Trial Summary
This trial aims to improve the rate of new PrEP prescriptions at a healthcare system by testing different intervention components, such as training for providers and patient education, in primary care settings. The goal is to
Who is the study for?
This trial is for primary care providers and patients at Henry Ford Health System. Providers must be over 18, able to prescribe in Michigan, and work at HFH. Patients also need to be over 18, have an EHR account, see a HFH provider during the study, and meet criteria for PrEP but not already be on it or HIV positive.Check my eligibility
What is being tested?
The trial tests how effective different interventions are in increasing new PrEP prescriptions in primary care. Interventions include alerts for providers and training simulations, as well as risk assessments and informational videos about PrEP for patients. The goal is to find efficient ways to prevent HIV.See study design
What are the potential side effects?
Since this trial focuses on educational tools rather than medications, there aren't direct side effects like with drug trials. However, participants may experience discomfort or privacy concerns when discussing personal health information.
MOST:PrEP Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ year 1 and year 5 electronic health record data pull.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~year 1 and year 5 electronic health record data pull.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Clinic-Level PrEP Prescription
Secondary outcome measures
Perceived HIV risk
PrEP Knowledge
PrEP awareness
+3 moreMOST:PrEP Trial Design
16Treatment groups
Experimental Treatment
Active Control
Group I: VideoExperimental Treatment1 Intervention
Patient PrEP Video only
Group II: Training, Risk Assessment, and VideoExperimental Treatment3 Interventions
Provider Training, Patient Risk Assessment, and Patient PrEP Video
Group III: Training, Best Practice Alert, and VideoExperimental Treatment3 Interventions
Provider Training, Best Practice Alert, and Patient PrEP Video
Group IV: Training, Best Practice Alert, and Risk AssessmentExperimental Treatment3 Interventions
Provider Training, Best Practice Alert, and Patient Risk Assessment
Group V: Training, Best Practice Alert, Risk Assessment, and VideoExperimental Treatment4 Interventions
Provider Training, Best Practice Alert, Patient Risk Assessment, and Patient PrEP Video
Group VI: Training and VideoExperimental Treatment2 Interventions
Provider Training and Patient PrEP Video
Group VII: Training and Risk AssessmentExperimental Treatment2 Interventions
Provider Training and Patient Risk Assessment
Group VIII: Training and Best Practice AlertExperimental Treatment2 Interventions
Provider Training and Best Practice Alert
Group IX: TrainingExperimental Treatment1 Intervention
Provider Training
Group X: Risk Assessment and VideoExperimental Treatment2 Interventions
Patient Risk Assessment and Patient PrEP Video
Group XI: Risk AssessmentExperimental Treatment1 Intervention
Patient Risk Assessment only
Group XII: Best Practice Alert, Risk Assessment and VideoExperimental Treatment3 Interventions
Best Practice Alert, Patient Risk Assessment, and Patient PrEP Video
Group XIII: Best Practice Alert and VideoExperimental Treatment2 Interventions
Best Practice Alert and Patient PrEP Video
Group XIV: Best Practice Alert and Risk AssessmentExperimental Treatment1 Intervention
Best Practice Alert and Patient Risk Assessment
Group XV: Best Practice AlertExperimental Treatment1 Intervention
Best Practice Alert only
Group XVI: No interventionActive Control1 Intervention
No intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Best Practice Alert
2019
N/A
~13340
Find a Location
Who is running the clinical trial?
New York UniversityOTHER
226 Previous Clinical Trials
312,718 Total Patients Enrolled
Henry Ford Health SystemLead Sponsor
301 Previous Clinical Trials
2,100,502 Total Patients Enrolled
University of South FloridaOTHER
413 Previous Clinical Trials
186,887 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are potential participants still able to enroll in this ongoing trial?
"Information from clinicaltrials.gov shows that this particular research is not currently open for participant recruitment. While it was initially posted on February 21, 2024, the last update occurred on March 26 of the same year. Despite its closure to enrollment, there are numerous other active trials seeking eligible participants at present."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger